1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Living Cell Technologies awarded exclusive pig cell patent for treatment of … – Proactive Investors Australia

February 1, 2012Other Transplantationadmin

Proactive Investors Australia

Living Cell Technologies awarded exclusive pig cell patent for treatment of ...
Proactive Investors Australia
This type of treatment is known as xenotransplantation. The patent, issued on January 3, 2012 by the United States Patent and Trademark Office, will be assigned to Diatranz Otsuka, a joint venture company between Living Cell and Otsuka Pharmaceutical ...

Post navigation

← LCT Granted USA Patent for Auckland Island Pigs – irasia.com (press release) A meeting of hearts if not minds – Middle East North Africa Financial Network →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos